Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda
Engineering Antibodies for Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
237-256
Author(s):
Leonard G. Presta
Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
275-283
Author(s):
Patrice Decker and Sylviane Muller
Development of DNA Topoisomerase II-Mediated Anticancer Agents, 3-(9- Acridinylamino)-5-hydroxymethylanilines (AHMAs) and Related Compounds
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1677-1688
Author(s):
Su Tsann-Long
Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson
The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
589-603
Author(s):
L. A. Beltz
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
605-612
Author(s):
M. Folini, M. Pennati and N. Zaffaroni
Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Journal:
Current Genomics
Volume:
3
Page:
245-263
Author(s):
S. Ortega, M. Malumbres and M. Barbacid
Studies of p53 Tumor Suppression Activity in Mouse Models
Journal:
Current Genomics
Volume:
3
Page:
265-283
Author(s):
Dionisio Martin-Zanca
ras Genes and Human Cancer: Different Implications and Different Roles
Journal:
Current Genomics
Volume:
3
Page:
295-311
Author(s):
Jose M. Rojas and Eugenio Santos